CD59 and neuroendocrine neoplasm: The latter has evolved from a single transcript approach to a multiple gene screen – 51 marker genes – that are closely correlated with neuroendocrine tumor biology [79] and overlap with genes e.g., APLP1 family, PNMA2 and CD59, in the current study.